News
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed ...
We are excited to welcome the talented team at Regulus to Novartis as we continue to build on our pipeline in renal disease with high unmet medical need.” Farabursen is an investigational ...
Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...
We came across a bullish thesis on Novartis AG (NVS) on Stock Analysis Compilation’s Substack. In this article, we will ...
See the latest Novartis AG Registered Shares stock price (NOVN:XSWX), related news, valuation, dividends and more to help you make your investing decisions.
Novartis AG offers growth potential with a balanced drug portfolio, manageable debt, and shares priced below fair value.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback